.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Moodys
Queensland Health
US Army
Baxter
QuintilesIMS
Harvard Business School
McKinsey
Argus Health
Daiichi Sankyo

Generated: September 26, 2017

DrugPatentWatch Database Preview

Albendazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for albendazole and what is the scope of albendazole freedom to operate?

Albendazole
is the generic ingredient in one branded drug marketed by Amedra Pharms Llc and Impax Labs Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for albendazole. Four suppliers are listed for this compound.

Summary for Generic Name: albendazole

Tradenames:1
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list9
Suppliers / Packagers: see list4
Bulk Api Vendors: see list91
Clinical Trials: see list80
Patent Applications: see list3,604
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:albendazole at DailyMed

Pharmacology for Ingredient: albendazole

Drug ClassAntihelminthic
Mechanism of ActionCytochrome P450 1A Inducers
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amedra Pharms Llc
ALBENZA
albendazole
TABLET, CHEWABLE;ORAL207844-001Jun 11, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
ALBENZA
albendazole
TABLET;ORAL020666-001Jun 11, 1996RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Deloitte
QuintilesIMS
Covington
Cantor Fitzgerald
Cipla
Chinese Patent Office
US Department of Justice
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot